Stockreport

Why Verve Therapeutics Is Skyrocketing Today [Yahoo! Finance]

Verve Therapeutics, Inc.  (VERV) 
PDF ET and had been up as much as 41% earlier in the session. Yesterday, Verve published promising data from its Heart-2 Phase 1b clinical trial of its VERVE-102 treatment [Read more]